Events & milestones
A calendar with context.
Track documented milestones and key dates. Future dates are conditional targets or deadlines, not confirmed public events.
No public events are scheduled at this time. Investor briefings, media conversations and clinical discussions are available by inquiry.
Request a conversation↗FDA docket comments ↗
Written comments to FDA-2025-N-6895.
FDA public testimony ↗
Three public testimony sessions.
Provisional filing window opens ↗
21 provisional patent applications filed September 15–21, 2026.
Series B PPM dated ↗
The Series B private placement memorandum is dated October 15, 2026.
HHS peptide policy notice ↗
Notice of availability published October 30, 2026.
Stated offering end date ↗
Subject to earlier termination or extension at company discretion. Confirm current availability directly.
Provisional conversion window ↗
Corresponding nonprovisional or PCT filings are due September 15–21, 2027.
HEAL WELL. AGE WELL. LIVE LONGER.